Terra Wonsettler, PharmD, MBA, vice president of pharmacy for Evolent, discusses the recent HHS OIG report that stemmed from ...

Regenerative Medicine Advanced Therapy (RMAT) designation follows Phase Ib 36-month data Study demonstrated favorable safety profile and continued positive trends in assessed clinical outcome measures ...

In response to a report from the Government Accountability Office, the FDA says the biggest stumbling block to conducting inspections of food facilities is understaffing. The Food and Drug ...

Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.

A spokesperson for the Department of Health and Human Services, which includes the CDC and FDA, did not respond to ... Vulnerability Index,” for example, was key to identifying high-risk hot ...

Throughout this period, the agency sought comment from interested stakeholders through public hearings and stakeholder meetings ... claim regulations. For example, FDA is proposing adjustments ...

For example, FDA’s Center for Devices and Radiological ... can be automatically substituted for the brand without meeting a higher bar requiring that a study be done to support interchangeability.

For example, any urgent messages regarding H5N1 ... cases reported in the U.S., according to the CDC. The move also means meetings with state and local health officials, training sessions and ...

"Seeing is believing," the founder of lab company Truvian told me. So I tried its tabletop blood testing device—which ...

Mary Kay Bates, senior global cell culture scientist at Thermo Fisher Scientific, explores best practices for implementing ...

CR tested 58 dog foods from brands including Blue Buffalo, Hill’s Science Diet, and Purina for key nutrients and dangerous ...